The week in review

With the end of PSA18 and controversy continuing around My Health Record, it’s been a busy week in the world of pharmacy

The PSA18 conference wrapped up, and PSA national president Shane Jackson outlined the PSA’s plans for the next few years, with remuneration high up on the list, while the Guild’s Anthony Tassone spoke at the conference calling for outcomes-based funding.

The My Health Record controversy still has a high profile, with Health Minister Greg Hunt announcing tighter privacy provisions following discussions with stakeholders. News Corp alleged, meanwhile, that the existing record had already been breached nine times.

The value of pharmacists in GP surgeries was also highlighted by new studies, while the Grattan Institute’s latest report claims that pharmacy is still stuck in the ‘horse and buggy’ era.

New guidelines were unveiled for the management of heart failure and atrial fibrillation; a study modelled future heatwave deaths, with bad news for people in Sydney, Melbourne and Brisbane; and the SHPA held a forum in Canberra on the future of opioid use in Australia.

There was movement in the world of sunscreen, as Bannister Law dropped its proposed class action against Banana Boat; shortly afterwards, the TGA announced the results of its review into sunscreens and found no compliance issues which concerned it.

And Greg Hunt announced new funding for awareness of hepatitis — in a push where pharmacists will have a key role.

Previous ‘I had to kind of pave the way.’
Next Looking back on PSA18

NOTICE: It can sometimes take awhile for comment submissions to go through, please be patient.

No Comment

Leave a reply